Key result
R-CHOP achieves persistent complete metabolic response in an elderly patient with biatrial primary cardiac lymphoma.
Why the study?
Primary cardiac lymphoma is a rare malignancy, and localization of the mass involving both sides of the heart is very rare.
Case Report (n=1)
Highlights a rare presentation of primary cardiac lymphoma with biatrial involvement successfully treated to complete metabolic response with 6 cycles of R-CHOP, underscoring the utility of cardiac MRI for tissue characterization.
Answers are grounded in this paper and cite their sources.
Clinicians should consider lymphoma in biatrial masses; this case extends the phenotypic spectrum but leaves optimal management open.
Background Primary cardiac lymphoma is a rare malignancy. Localisation of the mass in both sides of the heart is very rare. We report a case with a primary cardiac lymphoma with biatrial involvement. Case Summary An 80-year-old man presented to the emergency room with 3 weeks of shortness of breath. An X-ray showed an enlarged heart. Laboratory tests showed elevated CRP, NT-proBNP and d-dimer. A computed tomography pulmonary angiography showed a large mass in the right atrium with extension to the left atrium of 82x55mm. Cardiac MRI showed intermediate signal intensity on T1- and T2-weighted images and mild heterogeneous delayed enhancement. The mass was a primary cardiac lymphoma. After 6 cycles with R-CHOP, 18 weeks from diagnosis, patient had persistent complete metabolic response. Discussion This case presents a patient with a primary cardiac lymphoma with biatrial involvement, with the largest part in the right atrium. A review of the literature showed that in primary cardiac lymphomas with biatrial involvement and transseptal extension, the primary location/largest part of the mass is in the right atrium. Cardiac MRI is advised in cases with cardiac masses for tissue characterisation and mass extension.
No takes yet. Share an insight, caveat, or question.
Mulder et al. (2026) conducted a case report in Primary cardiac lymphoma with biatrial involvement (n=1). R-CHOP chemotherapy was evaluated on Metabolic response. R-CHOP chemotherapy (6 cycles) resulted in a persistent complete metabolic response at 18 weeks in an 80-year-old man with an 82x55mm biatrial primary cardiac lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: